These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 8457980)
1. Gram-negative sepsis: a dilemma of modern medicine. Bone RC Clin Microbiol Rev; 1993 Jan; 6(1):57-68. PubMed ID: 8457980 [TBL] [Abstract][Full Text] [Related]
2. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide. Fink MP Crit Care Med; 1993 Feb; 21(2 Suppl):S32-9. PubMed ID: 8428494 [TBL] [Abstract][Full Text] [Related]
3. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock. Calandra T; Baumgartner JD; Glauser MP Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424 [TBL] [Abstract][Full Text] [Related]
4. Passive immunotherapy of gram-negative bacteremia, sepsis and septic shock. Spapen HD; Diltoer M; Huyghens LP Acta Clin Belg; 1993; 48(1):20-9. PubMed ID: 7684546 [TBL] [Abstract][Full Text] [Related]
5. University of California/Davis Interdepartmental Conference on gram-negative septicemia. Young LS; Proctor RA; Beutler B; McCabe WR; Sheagren JN Rev Infect Dis; 1991; 13(4):666-87. PubMed ID: 1681579 [TBL] [Abstract][Full Text] [Related]
6. Management of neonatal sepsis by Gram-negative pathogens. Venkatesh MP; Garcia-Prats JA Expert Rev Anti Infect Ther; 2008 Dec; 6(6):929-38. PubMed ID: 19053905 [TBL] [Abstract][Full Text] [Related]
7. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Barriere SL; Guglielmo BJ Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812 [TBL] [Abstract][Full Text] [Related]
8. New strategies in nonantibiotic treatment of gram-negative sepsis. Cohn J; Bone RC Cleve Clin J Med; 1992; 59(6):608-15. PubMed ID: 1424072 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of bacteremia and intravascular catheter infections. Bullard KM; Dunn DL Am J Surg; 1996 Dec; 172(6A):13S-19S. PubMed ID: 9003685 [TBL] [Abstract][Full Text] [Related]
10. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody. Gorelick KJ; Chmel H Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775 [TBL] [Abstract][Full Text] [Related]
11. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group. McCloskey RV; Straube RC; Sanders C; Smith SM; Smith CR Ann Intern Med; 1994 Jul; 121(1):1-5. PubMed ID: 8198341 [TBL] [Abstract][Full Text] [Related]
12. Human monoclonal antibody against endotoxin. Zarowitz BJ DICP; 1991; 25(7-8):778-83. PubMed ID: 1949939 [TBL] [Abstract][Full Text] [Related]
13. Recent developments in our understanding of sepsis: evaluation of anti-endotoxin antibodies and biological response modifiers. Talan DA Ann Emerg Med; 1993 Dec; 22(12):1871-90. PubMed ID: 8239111 [TBL] [Abstract][Full Text] [Related]
15. Antibody to endotoxin in the treatment of gram-negative sepsis. McCabe WR JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763 [No Abstract] [Full Text] [Related]
16. Antibody to endotoxin in the treatment of gram-negative sepsis. van Deventer S JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765 [No Abstract] [Full Text] [Related]